Exero Medical scores $12.7M in funding and more digital funding news
Exero Medical, a company focused on early detection of post-operative complications using tissue healing data, has secured up to $12.7 million in funding to complete its FDA trial and launch its breakthrough-designated xBar system in the United States.
The round includes $10 million in upfront funding and additional milestone-based warrants, as well as $2.7 million in non-dilutive grants.
The round was led by Longevity Venture Partners, Tech Council Ventures and Edge Medical Ventures.
The funding will be used to support clinical and commercial activities.
“Exero Medical’s breakthrough xBar system has the potential to revolutionize post-operative care by providing critical real-time data to detect complications early,” Mark Kolb, partner at Tech Council Ventures, said in a statement. “Tech Council Ventures is proud to support Exero’s growth and expansion into the U.S. market.”
Vitalchat, an AI-powered ambient virtual care platform, announced it closed a $6 million Series A funding round led by Green Harvest Capital Industries.
The funding will be used to increase production innovation and market expansion as well as deeper AI integration into clinical workflows.
Additionally, the company announced that Ankit Patel, CEO of GHC Industries, will join the Vitalchat board.
“Doctors and nurses enter the profession to heal, comfort and care, not to be overwhelmed by paperwork or stretched thin due to staffing shortages,” Michael Raymer, CEO of Vitalchat, said in a statement.
“This funding enables us to scale our in-patient virtual care platform, allowing more health systems to give their care teams the time and focus to do what they love, connecting with patients and making a real difference in their lives,” he added.
Cerula Care, a cancer-focused collaborative behavioral health and care navigation company, announced an oversubscribed seed funding round of $3.7 million.
The round was led by Esplanade Ventures with participation from Amplify Capital, BrightEdge , DigiTx Partners, SpringTime Ventures and Mike Pykosz (former CEO and co-founder of Oak Street Health).
The funds will be used to expand services to more practices and invest further in patient-facing technology.
According to the company, the seed round comes in the wake of a strong pre-seed round, with Flare Capital Partners, Healthworx Accelerator and One Mind as participating investors.
“When someone is going through one of the scariest moments of their life, being told they have cancer, they get an oncologist focused on eradicating the cancer,” said Supriya Laknidhi, Cerula Care cofounder and CEO.
“However, the whole journey truly changes someone’s outlook on life, and no one is currently focused on improving the patient’s mental health. Cerula Care exists to help everyone going through the cancer journey have a better quality of life and ensures one coordinated team with their oncologist,” Laknidhi said.
